Πέμπτη 3 Μαρτίου 2016

Basilea Launches Antifungal CRESEMBA (isavuconazole) In Germany - Quick Facts - Nasdaq


Basilea Launches Antifungal CRESEMBA (isavuconazole) In Germany - Quick Facts
Nasdaq
... such as patients with cancer and after transplantation. Invasive aspergillosis is often fatal, while Mucormycosis (also known as zygomycosis) is a rapidly progressive and life-threatening invasive fungal infection, often affecting the nose and ...



from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Y8RLhS
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις